Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Thrombotic Potential (Thrombin Generation) of Left Atrium and Other Heart Chambers in Atrial Fibrillation Patients Compared to Patients Without Atrial Fibrillation.

NCT03795883 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT03795883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03795883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Thrombotic Potential (Thrombin Generation) of Left Atrium and Other Heart Chambers in Atrial Fibrillation Patients Compared to Patients Without Atrial Fibrillation.
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
March 9, 2022
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, left atrial thrombosis, thrombosis cardiac